← Back to Search

Educational Support for Lung Cancer Screening

N/A

Recruiting

Research Sponsored by Thomas Jefferson University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to 5 years

Awards & highlights

Study Summary

This trial looks at how educating patients and providers on lung cancer screening can help find the cancer earlier and increase screening rates.

Who is the study for?

This trial is for adults aged 50-77 who currently smoke or quit within the last 15 years, with a significant smoking history. They must be able to communicate in English or Spanish and have an upcoming primary care visit. Excluded are those recently hospitalized, with dementia, prior lung cancer, or recent CT scans.Check my eligibility

What is being tested?

The study evaluates if education and counseling can increase lung cancer screening rates among smokers or recent quitters. It involves survey administration, electronic health record review, and educational activities aimed at both healthcare providers and patients.See study design

What are the potential side effects?

Since this trial focuses on education and counseling rather than medication or invasive procedures, traditional side effects are not applicable. However, participants may experience stress or anxiety related to learning about their risk of lung cancer.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to 5 years

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to 5 years

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Completion of initial lung cancer screening (LCS)

Secondary outcome measures

Diagnostic follow up after initial lung cancer screening

Referral for LCS

Repeat annual lung cancer screenings within 11-16 months of original screening

+1 more

Trial Design

4Treatment groups

Experimental Treatment

Active Control

Group I: Group A (Providers): (survey, online educational activity)Experimental Treatment2 Interventions

Participants complete survey on study. Participants undergo online educational activity on study. Participants undergo distance learning on study.

Group II: Group A (Patients): (EHR, educational activity, counseling))Experimental Treatment3 Interventions

Patients undergo EHR review on study. Patients undergo educational activity on study. Patients also undergo SDM counseling once on study.

Group III: Group B (Patients): (survey)Active Control2 Interventions

Patients undergo EHR review on study and complete telephone survey throughout the trial.

Group IV: Group B (Providers): (survey)Active Control1 Intervention

Participants complete survey at baseline and end of study survey.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Thomas Jefferson UniversityLead Sponsor

445 Previous Clinical Trials

144,617 Total Patients Enrolled

Media Library

Group A (Patients): (EHR, educational activity, counseling)) Clinical Trial Eligibility Overview. Trial Name: NCT05679349 — N/A

Lung Cancer Research Study Groups: Group B (Patients): (survey), Group A (Patients): (EHR, educational activity, counseling)), Group A (Providers): (survey, online educational activity), Group B (Providers): (survey)

Lung Cancer Clinical Trial 2023: Group A (Patients): (EHR, educational activity, counseling)) Highlights & Side Effects. Trial Name: NCT05679349 — N/A

Group A (Patients): (EHR, educational activity, counseling)) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05679349 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this research endeavor enlist participants aged 25 and older?

"This study stipulates that only patients between the ages of 50 and 77 are eligible for enrollment. Conversely, there are 73 trials recruiting participants below 18 years old and 2396 targeting those over 65."

Answered by AI

Is there availability for prospective participants in this clinical trial?

"As indicated by the clinicaltrials.gov information, this medical study is not in need of participants at present. Originally posted on January 1st 2023 and updated last December 23rd 2022, no new patients are to be enrolled for now; nonetheless, 2,421 alternative trials have currently opened their recruitment activities."

Answered by AI

What criteria must be satisfied for one to qualify for this research project?

"This medical trial is recruiting 822 people with a history of lung cancer, aged between 50 and 77. To be eligible for the study, applicants must meet these criteria: Possess primary care qualifications (geriatrics, family medicine or internal medicine) from one of 4 associated health systems; Use an appropriate EMR system in their practice; Have at least 50% of providers consent to take part; Schedule either office/telemedicine patient visit within 14-25 days; Report 20+ pack-year smoking history (self-reported); Smoke currently or have quit within 15 years (also self-reported); Communicate fluently in English"

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Support and Outreach to Increase Screening for Lung Cancer in Patients With a History of Smoking

2023. "Support and Outreach to Increase Screening for Lung Cancer in Patients With a History of Smoking". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05679349.